#cardiometabolic - Techseriesinsight

June 18, 2025
PRNewswire
Networking, News

Petauri™ Further Expands Global Pricing and Market Access Capabilities With Key Leadership Hires

Petauri, a leading purpose-built pharmaceutical services platform, announced today the addition of accomplished consultants Catherine Beecher and Sam Davies as Directors in Petauri Evidence, further strengthening the organization’s Global Pricing and Market Access...

June 18, 2025
PRNewswire
Healthcare

Healthy Interactions Primary Care Alliance Supports Clinics to Improve Cardiometabolic Care

Healthy Interactions LLC, a global leader in experiential education for healthcare professionals and patients, is teaming up with the DARTNet Institute, to accelerate transformation of primary care by driving structural and...

May 6, 2025
PRNewswire
Biotechnology

Galmed Announces First Time Results in Oncology Studies: Aramchol Significantly Enhances Bayer’s Regorafenib Effect in GI Cancer Models

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) (“Galmed” or the “Company”), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI oncological therapeutics, announced today that the first set of oncology studies has...